OTHER SYNTHETICS
BILL STATUS REPORT – CARRYOVER,
2012, AND SPECIAL SESSIONS
This project was supported by Cooperative Agreement No. 2012-DC-BX-K002 awarded by the Bureau of
Justice Assistance. The Bureau of Justice Assistance is a component of the Office of Justice Programs,
which also includes the Bureau of Justice Statistics, the National Institute of Justice, the office of Juvenile
Justice and Delinquency Prevention, the office for Victims of Crime, the Community Capacity
Development Office, and the Office of Sex Offender Sentencing, Monitoring, Apprehending, Registering,
and Tracking. Points of view or opinions in this document are those of the author and do not necessarily
represent the official position or policies of the U.S. Department of Justice.
© 2012 Research is current as of August 24, 2012. In order to ensure that the information contained herein is as current as
possible, research is conducted using both nationwide legal database software and individual state legislative websites. Please
contact Heather Gray at (703) 836-6100, ext. 114 or [email protected] with any additional updates or information that may be
relevant to this document. This document is intended for educational purposes only and does not constitute legal advice or
opinion. Headquarters Office: THE NATIONAL ALLIANCE FOR MODEL STATE DRUG LAWS. 215 Lincoln Ave. Suite
201, Santa Fe, NM 87501.
State
Bill No.
Brief Description
Colorado
S.B. 116
Adds MPHP
Colorado
H.B. 1310
Adds MPHP
D.C.
Adds 2C-T-7, 5-MeO-DiPT
Florida
L.B. B19645
H.B. 1175
Florida
S.B. 1502
Georgia
S.B. 370
adds 2C-C, 2C-E, 2C-I, 2C-T-2, 2C-T-4, 2CT-7, 5-MeO-DiPT, 5-MeO-DMT,
chlorophenylpiperazine, DiPT, DOC, DOI,
DPT, fluorophenylpiperazine,
methyltryptamine, MPHP, TFMPP
adds 2C-C, 2C-E, 2C-I, 2C-T-2, 2C-T-4, 2CT-7, 5-MeO-DiPT, 5-MeO-DMT,
chlorophenylpiperazine, DiPT, DOC, DOI,
DPT, fluorophenylpiperazine,
methyltryptamine, MPHP, TFMPP
Adds fluorophenylpiperazine
Hawaii
H.B. 2600
Adds 5-MeO-DMT
Hawaii
S.B. 2862
Adds 5-MeO-DiPT, 5-MeO-DMT
Idaho
H.B. 502
Adds 5-MeO-DMT
Indiana
H.B. 1196
Adds 6-APB, methoxetamine
Indiana
S.B. 234
Adds 6-APB, methoxetamine
Indiana
S.B. 26
Adds 6-APB, methoxetamine
Iowa
H.F. 2398
adds 2C-C, 2C-E, 2C-I, 2C-T-2, 2C-T-4
Iowa
H.S.B. 609
adds 2C-C, 2C-E, 2C-I, 2C-T-2, 2C-T-4
Iowa
S.S.B.
3104
S.F. 2341
Iowa
Status
Second reading
laid over daily
Signed by
Governor
Hearing held
Date of
Last
Action
5/8/2012
6/7/2012
3/16/2012
Signed by
Governor
3/23/2012
Substituted by
H.B. 1175; laid
on the table
3/6/2012
3/27/2012
adds 2C-C, 2C-E, 2C-I, 2C-T-2, 2C-T-4
Signed by
Governor
Signed by
Governor
Referred to
committee
Signed by
Governor
Signed by
Governor
Senate dissented
from House
amendments;
conferees and
advisors
appointed
Signed by
Governor
Passed House; in
Senate
committee
Voted – public
safety
introduced
Adds 2C-C, 2C-E, 2C-I, 2C-T-2, 2C-T-4
Introduced and
4/25/2012
4/19/2012
1/25/2012
3/29/2012
3/15/2012
3/8/2012
3/19/2012
3/15/2012
2/23/2012
1/30/2012
© 2012 Research is current as of August 24, 2012. In order to ensure that the information contained herein is as current as
possible, research is conducted using both nationwide legal database software and individual state legislative websites. Please
contact Heather Gray at (703) 836-6100, ext. 114 or [email protected] with any additional updates or information that may be
relevant to this document. This document is intended for educational purposes only and does not constitute legal advice or
opinion. Headquarters Office: THE NATIONAL ALLIANCE FOR MODEL STATE DRUG LAWS. 215 Lincoln Ave. Suite
201, Santa Fe, NM 87501.
Iowa
S.F. 2343
Adds 2C-C, 2C-E, 2C-I, 2C-T-2, 2C-T-4
Kentucky
S.B. 188
adds TFMPP
Kentucky
H.B. 481
adds TFMPP
Kentucky
S.B. 173
adds TFMPP
Kentucky
H.B. 198
adds TFMPP
Kentucky
H.B. 176
adds TFMPP
Kentucky
H.B. 185
adds TFMPP
Louisiana
S.B. 195
Adds phenazepam
Massachusetts H.B. 4383
Adds MPHP
Minnesota
S.F. 2319
Minnesota
H.F. 2508
Mississippi
H.B. 730
adds 2C-C, 2C-T-4, 2C-T-7, 4-HO-DiPT, 5IAI, 5-MeO-DALT, 5-MeO-DiPT, 5-MeOMiPT, 6-APB, DiPT, DOC, DOI,
methoxetamine
adds 2C-C, 2C-T-4, 2C-T-7, 4-HO-DiPT, 5IAI, 5-MeO-DALT, 5-MeO-DiPT, 5-MeOMiPT, 6-APB, DiPT, DOC, DOI,
methoxetamine
Adds 5-MeO-DMT
Mississippi
S.B. 2463
Adds 5-MeO-DMT
New York
S.B. 5181
Adds 2C-E
New York
A.B. 7917
Adds 5-MeO-DMT
New York
S.B. 4460
Adds 5-MeO-DMT
New York
A.B. 5008
Adds TFMPP
referred to
committee
Signed by
Governor
In Senate
committee
Signed by
Governor
In Senate
committee
In House
committee
In House
committee
In House
committee
Signed by
Governor
Referred to
House
committee
Substituted by
HF2508 on
general orders
5/25/2012
3/5/2012
4/11/2012
2/28/2012
1/5/2012
1/4/2012
1/4/2012
5/28/2012
8/9/2012
3/30/2012
Signed by
Governor
4/27/2012
Signed by
Governor
Died in
committee
Recommit to
committee;
enacting clause
stricken
Passed
Assembly;
referred to
Senate
committee
Referred to
committee
Referred to
5/1/2012
3/6/2012
1/9/2012
2/15/2012
1/4/2012
1/4/2012
© 2012 Research is current as of August 24, 2012. In order to ensure that the information contained herein is as current as
possible, research is conducted using both nationwide legal database software and individual state legislative websites. Please
contact Heather Gray at (703) 836-6100, ext. 114 or [email protected] with any additional updates or information that may be
relevant to this document. This document is intended for educational purposes only and does not constitute legal advice or
opinion. Headquarters Office: THE NATIONAL ALLIANCE FOR MODEL STATE DRUG LAWS. 215 Lincoln Ave. Suite
201, Santa Fe, NM 87501.
New York
S.B. 7009
New York
A.B.
10448
Oklahoma
H.B. 2942
Adds 2C-C, 2C-E, methoxetamine, 5MeO-DALT, 5-MeO-DIPT, 4-MeO-PCP, 5IAI, 6-APB
Adds methoxetamine, 2C-C, 5-MeODALT, 5-MeO-DIPT, 4-MeO-PCP, 5-IAI, 6APB
Adds DOC
South Dakota
S.B. 23
adds 2C-C, 2C-E, 2C-I, 2C-T-2, 2C-T-4
Tennessee
S.B. 2230
adds 5-MeO-DMT
Tennessee
H.B. 2368
adds 5-MeO-DMT
Virginia
S.B. 273
Virginia
H.B. 508
Virginia
H.B. 986
adds 2C-E, 2C-I, 5-MeO-DALT; Governor
recommends adding 25I-NBOMe,
methoxetamine, 4-FMA, and 4-FA
adds 2C-E, 2C-I, 5-MeO-DALT; Governor
recommends adding 25I-NBOMe,
methoxetamine, 4-FMA, and 4-FA
adds 2C-E, 2C-I, 5-MeO-DALT
Virginia
S.B. 223
adds 2C-E, 2C-I, 5-MeO-DALT
West Virginia
S.B. 667
adds 2C-T-7, 5-MeO-DiPT, 5-MeO-DMT
United States
HR 1254
adds 2C-C, 2C-E, 2C-I, 2C-T-2, 2C-T-4
United States
S 839
adds 2C-C, 2C-E, 2C-I, 2C-T-2, 2C-T-4
United States
S 3189
Adds 2C-C, 2C-I, 2C-T-2, 2C-T-4
United States
S 3187
Adds 2C-C, 2C-I, 2C-T-2, 2C-T-4
United States
S 3190
Adds 2C-C, 2C-I, 2C-T-2, 2C-T-4
committee
Referred to
committee
4/20/2012
Referred to
committee
5/29/2012
Signed by
Governor
Signed by
Governor
Signed by
Governor
Companion SB
substituted
Signed by
Governor
4/17/2012
Signed by
Governor
4/18/2012
Left in courts of
justice
Incorporated
into S.B. 273
Referred to
committee
Passed House;
referred to
Senate
committee
Placed on Senate
legislative
calendar
Read twice and
referred to
committee
Signed by
President
Read twice and
referred to
committee
2/14/2012
2/24/2012
4/26/2012
4/4/2012
4/18/2012
1/23/2012
2/22/2012
12/8/2011
7/28/2011
5/16/2012
7/9/2012
5/16/2012
* Red text indicates the legislative session has adjourned sine die.
© 2012 Research is current as of August 24, 2012. In order to ensure that the information contained herein is as current as
possible, research is conducted using both nationwide legal database software and individual state legislative websites. Please
contact Heather Gray at (703) 836-6100, ext. 114 or [email protected] with any additional updates or information that may be
relevant to this document. This document is intended for educational purposes only and does not constitute legal advice or
opinion. Headquarters Office: THE NATIONAL ALLIANCE FOR MODEL STATE DRUG LAWS. 215 Lincoln Ave. Suite
201, Santa Fe, NM 87501.